Connor J. Dwyer

Medical University of South Carolina — United States

Immunology and Microbiology · Life Sciences

15h-index1.4kcitations108works0.12yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(63), CAR-T cell therapy research(61), Cancer Immunotherapy and Biomarkers(28), Immunotherapy and Immune Responses(18), T-cell and B-cell Immunology(8)

Publications108 total

T-cell Priming by High-Avidity Neoantigens in Lymph Nodes Augments Adoptive Immunotherapy

Cancer Immunology Research·2025Open Access

Supplemental Table 1 from mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity

2025Open Access

Supplemental Table 5 from mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity

2025Open Access

Supplemental Table 2 from mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity

2025Open Access

Supplemental Figures from mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity

2025Open Access

Supplemental Table 4 from mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity

2025Open Access

Supplemental Table 3 from mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity

2025Open Access

964 Development of conditional T cell engagers (INDUCER™ molecules) with a highly effective masking approach to reduce dose-limiting cytokine release and off-target peripheral toxicity

Regular and Young Investigator Award Abstracts·2025Open Access

B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity

UNC Libraries·2025Open Access

Multivalent Exosome Based Protein Vaccine: A “Mix and Match” Approach to Epidemic Viruses’ Challenges

3 cited

Vaccines·2025· 3 citedOpen Access

955 INDUKINE™ molecules delivering various cytokines utilize unique mechanisms of action to drive anti-tumor efficacy in murine syngeneic tumor models

Regular and Young Investigator Award Abstracts·2024Open Access

Supplemental Table 1 from mWTX-330, an IL 12 INDUKINE Molecule, Activates and Reshapes Tumor-infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity

2024Open Access

Supplemental Table 2 from mWTX-330, an IL 12 INDUKINE Molecule, Activates and Reshapes Tumor-infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity

2024Open Access

Supplemental Table 4 from mWTX-330, an IL 12 INDUKINE Molecule, Activates and Reshapes Tumor-infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity

2024Open Access

Supplemental Figures from mWTX-330, an IL 12 INDUKINE Molecule, Activates and Reshapes Tumor-infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity

2024Open Access

Supplemental Table 3 from mWTX-330, an IL 12 INDUKINE Molecule, Activates and Reshapes Tumor-infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity

2024Open Access

Data from mWTX-330, an IL 12 INDUKINE Molecule, Activates and Reshapes Tumor-infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity

2024Open Access

Supplemental Table 4 from mWTX-330, an IL 12 INDUKINE Molecule, Activates and Reshapes Tumor-infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity

2024Open Access

Supplemental Table 1 from mWTX-330, an IL 12 INDUKINE Molecule, Activates and Reshapes Tumor-infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity

2024Open Access

Supplemental Table 5 from mWTX-330, an IL 12 INDUKINE Molecule, Activates and Reshapes Tumor-infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity

2024Open Access

page 1 of 6Next →

Frequent Co-authors

Hannah M. Knochelmann(18), Chrystal M. Paulos(18), Aubrey S. Smith(17), Megan M. Wyatt(17), Guillermo O. Rangel Rivera(16), Christopher J. Nirschl(13), Heather R. Brodkin(13), Daniel J. Hicklin(13), Cynthia Seidel‐Dugan(13), William M. Winston(13), Andrés Salmerón(13), Celesztina Domonkos(12), Nesreen Ismail(12), Philipp Steiner(12), Zoe Steuert(12), Jenna M. Sullivan(12), Mark P. Rubinstein(11), Jessica E. Thaxton(8), Gregory B. Lesinski(6), Zihai Li(5)